Evidence-Based Reviews

Risk Evaluation and Mitigation Strategy programs: How they can be improved

Author and Disclosure Information

 

References

Ensure adequate stakeholder input during the REMS development and real-world testing in multiple environments before implementing the REMS to identify unanticipated consequences that might impact patient access, patient safety, and health care professional burden. Implementation testing should explore issues such as purchasing and procurement, billing and reimbursement, and relevant factors such as other federal regulations or requirements (eg, the DEA or Medicare).

Ensure harmonization of the REMS forms and processes (eg, initiation and monitoring) for different medications where possible. A prescriber, pharmacist, or system should not face additional barriers to participate in a REMS based on REMS-specific intricacies (ie, prescription systems, data submission systems, or ordering systems). This streamlining will likely decrease clinical inertia to initiate care with the REMS medication, decrease health care professional burden, and improve compliance with REMS requirements.

REMS should anticipate the need for care transitions and employ provisions to ensure seamless care. Considerations should be given to transitions that occur due to:

  • Different care settings (eg, inpatient, outpatient, or long-term care)
  • Different geographies (eg, patient moves)
  • Changes in clinicians, including leaves or absences
  • Changes in facilities (eg, pharmacies).

REMS should mirror normal health care professional workflow, including how monitoring data are collected and how and with which frequency pharmacies fill prescriptions.Enhanced information technology to support REMS programs is needed. For example, REMS should be integrated with major electronic patient health record and pharmacy systems to reduce the effort required for clinicians to supply data and automate REMS processes.

For medications that are subject to other agencies and their regulations (eg, the CDC, Centers for Medicare & Medicaid Services, or the DEA), REMS should be required to meet all standards of all agencies with a single system that accommodates normal health care professional workflow.

Continue to: REMS should have a...

Pages

Recommended Reading

Young men at highest schizophrenia risk from cannabis abuse
MDedge Psychiatry
Choosing our terms: The diagnostic words we use can be harmful
MDedge Psychiatry
Black patients most likely to be restrained in EDs, Latino patients least likely
MDedge Psychiatry
When a patient wants to stop taking their antipsychotic: Be ‘A SPORT’
MDedge Psychiatry
Dysphagia in a patient with schizophrenia: Is the antipsychotic the culprit?
MDedge Psychiatry
Quick medication, better communication linked to less violence at inpatient psych unit
MDedge Psychiatry
Psychiatrists: Don’t fear clozapine in treatment-resistant schizophrenia
MDedge Psychiatry
Music therapy helps motivate patients with schizophrenia
MDedge Psychiatry
Ketamine may be a viable alternative to ECT for severe depression
MDedge Psychiatry
Tips for addressing uptick in mental health visits: Primary care providers collaborate, innovate
MDedge Psychiatry